Leg Cramps
NDC 70163-0005, Chininum Sulphuricum, Colocynthis, Gnaphalium Polycephalum, Lycopodium Clavatum, Magnesia Phosphorica, Calcarea Carbonica, Rhus Tox, Cuprum Metallicum, tablet, from NaturalCare.
- Product NDC
- 70163-0005
- Status
- Listed
- Labeler
- NaturalCare
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70163-0005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- QUININE SULFATE4 [hp_X]/1
- CITRULLUS COLOCYNTHIS FRUIT PULP4 [hp_X]/1
- PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE4 [hp_X]/1
- LYCOPODIUM CLAVATUM SPORE6 [hp_X]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE6 [hp_X]/1
- OYSTER SHELL CALCIUM CARBONATE, CRUDE6 [hp_X]/1
- TOXICODENDRON PUBESCENS LEAF6 [hp_X]/1
- COPPER12 [hp_X]/1
Pharmacologic classes
Antimalarial [EPC]; Calculi Dissolution Agent [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70163-0005-1 | 70163000501 | 1 BLISTER PACK in 1 CONTAINER (70163-0005-1) / 60 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70163-0005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70163-0005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70163-0005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.